Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| CGM & insulin pump management · Massachusetts | CGM & insulin pump management · New York | |
|---|---|---|
| Surgeons, 2024 | 240 | 496 |
| Medicare fee-for-service cases | 25,322 | 58,834 |
| Growth since 2019 (Medicare FFS) | +25%/yr | +16%/yr |
| Forecast cases (Medicare FFS) | 50,400 in 2030 | 98,600 in 2030 |
| Forecast growth | +12%/yr to 2030 | +9%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 26.4 | 31.7 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 64% (−14 pts since 2019) | 89% (−5 pts since 2019) |
| Cases per surgeon | 106 | 119 |
| Top 10 surgeons' share | 16% | 17% |
| Surgeons growing | 96 | 174 |
| New since the base year | 102 | 215 |
| Likely to stop billing it | 9 by 2026 | 19 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $824 | $1,578 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.